Reported Apr 20, 2016 · Terminated

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Becton, Dickinson and Company, BD Biosciences

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Becton, Dickinson and Company, BD Biosciences · 2350 Qume Dr · San Jose, CA · 95131-1812

Is this the product you have?

  • BD-Retic-Count Reticulocyte Reagent System
  • HematologyUsed for in vitro diagnostics
Lot codes and dates
    • Product number 349214
    • Lot number 5175559
    • Expiry 5/31/16
Amount recalled
205

Where it was sold

Why it was recalled

The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Becton, Dickinson and Company, BD Biosciences recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Notice updated Dec 2, 2016 · Data as of Sep 19, 6:46 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.